Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Didox

Catalog No. T7525Cas No. 69839-83-4
Alias NSC-324360

Didox (NSC-324360) is a synthetic ribonucleotide reductase (RR) inhibitor shown to reduce oxidative injury markers in the brains of HIV patients with dementia.

Didox

Didox

Purity: 96.85%
Catalog No. T7525Alias NSC-324360Cas No. 69839-83-4
Didox (NSC-324360) is a synthetic ribonucleotide reductase (RR) inhibitor shown to reduce oxidative injury markers in the brains of HIV patients with dementia.
Pack SizePriceAvailabilityQuantity
5 mg$30In Stock
10 mg$38In Stock
25 mg$83In Stock
50 mg$127In Stock
100 mg$196In Stock
500 mg$473In Stock
1 mL x 10 mM (in DMSO)$31In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Didox"

Select Batch
Purity:96.85%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Didox (NSC-324360) is a synthetic ribonucleotide reductase (RR) inhibitor shown to reduce oxidative injury markers in the brains of HIV patients with dementia.
In vitro
Didox induced cell death and that this effect was suppressed by iron supplementation.?Cell treatments with didox caused changes of cellular iron content, TfR1 and ferritin levels comparable to those caused by the iron chelators, deferoxamine (DFO) and deferiprone (DFP).Didox is a bidentated iron chelator with two theoretical possible positions for the binding and among them that with the two hydroxyls of the catechol group acting as ligands is the more likely one. The iron chelating property of didox may contribute to its antitumor activity not only blocking the formation of the tyrosil radical on Tyr122 (such as HU) on RRM2 (essential for its activity) but also sequestering the iron needed by this enzyme and to the cell proliferation[1].
In vivo
Didox treatment of mouse bone marrow-derived mast cells (BMMC) reduced IgE-stimulated degranulation and cytokine production, including IL-6, IL-13, TNF and MIP-1a (CCL3)[2].
Cell Research
The cells were seeded in a 96-well plate (at a density of 2 × 10^3 cells for HA22T/VGH;?1.5 × 103 cells for HuH7) and exposed to various concentrations of didox and only HA22T/VGH also to hydroxyurea, DFO or DFP (0, 1, 10, 25, 50, 100, 200 and 500 μM) for 24, 48 and 72 h. In other experiments, HA22T/VGH were seeded in 96-well plates and treated with a single dose of didox, HU, DFO, DFP alone or in combination with increasing doses of FAC (25, 50, 100, 200 and 400 μM) for 48–72 h. In other type of treatment,?HA22T/VGH cells were or pre-treated for 16 h with a single dose of didox (200 μM) and then treated in combination with FAC (400–800 μM) or directly in combination didox-FAC for 48–72 h.Cell viability was evaluated with an MTT assay.?After the indicated time points and treatments, the supernatant was removed and 100 μL of the MTT solution (0.5 mg/mL) diluted in the cell medium was added to the wells.?After 3.5 h of incubation at 37 °C and 5% CO2, the MTT medium was removed and 75 μL of DMSO was added to each well.?Plates were shaken for 15 min at 37 °C until complete dissolution and absorbance was measured at 540 nm emission wavelengths.?Average percentage of cell viability at each concentration was calculated using Microsoft Excel 2016 software[1].
AliasNSC-324360
Chemical Properties
Molecular Weight169.13
FormulaC7H7NO4
Cas No.69839-83-4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (591.26 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM5.9126 mL29.5631 mL59.1261 mL295.6306 mL
5 mM1.1825 mL5.9126 mL11.8252 mL59.1261 mL
10 mM0.5913 mL2.9563 mL5.9126 mL29.5631 mL
20 mM0.2956 mL1.4782 mL2.9563 mL14.7815 mL
50 mM0.1183 mL0.5913 mL1.1825 mL5.9126 mL
100 mM0.0591 mL0.2956 mL0.5913 mL2.9563 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Didox | purchase Didox | Didox cost | order Didox | Didox chemical structure | Didox in vivo | Didox in vitro | Didox formula | Didox molecular weight